supp.fit

Green Lipped Mussel

6 benefits mapped to clinical evidence across supplements.

Dose per serving from research

7 study groups in 4 studies say how much Green Lipped Mussel participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g and 10 g to 25 g, 29% of 7 study groups each.

Daily doseStudy groups
500 mg or less
1
500 mg to 1 g
0
1 g to 2.5 g
1
2.5 g to 5 g
2
5 g to 10 g
0
10 g to 25 g
2
25 g to 50 g
0
50 g to 100 g
0
over 100 g
1

See every study group

Benefit Evidence

Pain/function improved

Activity/lameness improved

271 people

Pain/function improve

Activity improves +P<0.001

240 people

Activity + mobility

Pain/function

240 people

Pain/function improves

Airway inflammation drops

136 people

Reduced airway inflammation

Better asthma control

96 people

Activity/mobility +

Pain/recovery -

40 people

Research sources

Joint comfort (6)
  1. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs

    PubMed ID: 15136981

    Related/duplicate report of the same canine benefit data showing improved arthritis signs.

  2. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease

    PubMed ID: 16751841

    Dogs with DJD showed a higher rate of clinical improvement vs placebo after GLM extract.

  3. Evaluation of a therapeutic diet for feline degenerative joint disease

    PubMed ID: 20337921

    Diet containing GSM extract (with EPA/DHA + glucosamine/chondroitin) increased activity and improved mobility in cats with DJD.

  4. Perna canaliculus lipid complex PCSO-524™ demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control

    PubMed ID: 23739042

    PCSO‑524™ produced large, clinically meaningful pain and function improvements in older adults with OA vs fish oil.

  5. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles

    PubMed ID: 22821424

    GLM improved WOMAC/Lequesne OA symptom scores over 12 weeks (clinical symptom improvement).

  6. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs

    PubMed ID: 19753702

    Double‑blind canine trial: dietary GLM reduced total arthritis scores and improved pain/swelling.

Healthy aging (5)
  1. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease

    PubMed ID: 16751841

    Dogs with DJD had higher improvement rates with GLME vs placebo by Day 56—evidence for benefit in degenerative (aging) joints.

  2. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs

    PubMed ID: 19753702

    Canine trial showed arthritis sign reductions with dietary GLM—relevant to aging joint care though animal data.

  3. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles

    PubMed ID: 22821424

    Symptom improvements with GLM in knee OA indicate support for degenerative joint conditions.

  4. Perna canaliculus lipid complex PCSO-524™ demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control

    PubMed ID: 23739042

    PCSO‑524™ produced marked pain and function improvements in older adults with OA—strong clinical signal for supporting aging joints.

  5. Evaluation of a therapeutic diet for feline degenerative joint disease

    PubMed ID: 20337921

    GSM‑containing diet improved mobility in older animals with degenerative joint disease—supports aging joint function.

Joint mobility (5)
  1. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles

    PubMed ID: 22821424

    Symptom score improvements with GLM suggest better movement in knee OA subjects.

  2. Perna canaliculus lipid complex PCSO-524™ demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control

    PubMed ID: 23739042

    Marked reductions in pain and improved function in OA patients on PCSO‑524™ indicate easier movement.

  3. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease

    PubMed ID: 16751841

    Higher proportion of dogs improved clinically on GLME vs placebo—supports better movement.

  4. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs

    PubMed ID: 19753702

    Canine data show improved clinical arthritis signs consistent with easier movement.

  5. Evaluation of a therapeutic diet for feline degenerative joint disease

    PubMed ID: 20337921

    Accelerometer data in cats showed a clear and significant increase in physical activity and mobility with GLM diet.

Inflammation (3)
  1. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial

    PubMed ID: 12358334

    LyprinolÂŽ reduced exhaled H2O2 (airway oxidative/inflammatory marker) in asthmatics.

  2. Perna canaliculus lipid complex PCSO-524™ demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control

    PubMed ID: 23739042

    Rapid clinical improvements in OA with PCSO‑524™ are consistent with anti‑inflammatory action.

  3. Evaluation of a therapeutic diet for feline degenerative joint disease

    PubMed ID: 20337921

    Improved mobility and pain in cats on GLM diet are consistent with reduced inflammatory joint burden.

Immune support (2)
  1. Perna canaliculus lipid complex PCSO-524™ demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control

    PubMed ID: 23739042

    PCSO‑524™ produced clinical improvements in OA and has plausible immunomodulatory/anti‑inflammatory effects reported.

  2. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial

    PubMed ID: 12358334

    Lyprinol® reduced wheeze and exhaled H2O2 and improved PEF in steroid‑naïve atopic asthma—evidence of immune/airway anti-inflammatory action.

Stress resilience (1)
  1. Evaluation of a therapeutic diet for feline degenerative joint disease

    PubMed ID: 20337921

    Increased activity and mobility in cats suggests greater functional resilience to joint disease.

Similar by evidence

Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.

Products with Green Lipped Mussel

Search all

7 products whose verified label declares Green Lipped Mussel — not every bottle that mentions it in a title.